Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;37(5):2051-2066.
doi: 10.1002/ptr.7806. Epub 2023 Mar 31.

Berberine and health outcomes: An umbrella review

Affiliations

Berberine and health outcomes: An umbrella review

Zhongyu Li et al. Phytother Res. 2023 May.

Abstract

Berberine is a plant extract widely used in clinical practice. This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health-related outcomes. The PubMed, Cochrane Library, and Embase databases were searched for meta-analyses of randomized controlled trials (RCTs) assessing the efficacy and safety of berberine from inception to June 30, 2022. The AMSTAR-2 and GRADE system were used to assess the methodological quality and evidence level of the included meta-analyses. A total of 11 eligible meta-analyses were identified from 235 publications, which were published in peer-reviewed journals between 2013 and 2022. The results revealed that berberine significantly affects blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections as compared to controls. Common side effects of berberine consumption include gastrointestinal symptoms, such as constipation and diarrhea. Berberine is a safe medicinal plant ingredient that improves various clinical outcomes; however, there is a need for improvement of methodological quality in published meta-analyses. Additionally, the clinical effects of berberine need to be confirmed in high-quality RCTs.

Keywords: AMSTAR-2; berberine; health outcomes; meta-analysis.

PubMed Disclaimer

References

REFERENCES

    1. Allers, K., Hoffmann, F., Mathes, T., & Pieper, D. (2018). Systematic reviews with published protocols compared to those without: More effort, older search. Journal of Clinical Epidemiology, 95, 102-110. https://doi.org/10.1016/j.jclinepi.2017.12.005
    1. Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132-140. https://doi.org/10.1097/XEB.0000000000000055
    1. Asbaghi, O., Ghanbari, N., Shekari, M., Reiner, Ž., Amirani, E., Hallajzadeh, J., Mirsafaei, L., & Asemi, Z. (2020). The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 38, 43-49. https://doi.org/10.1016/j.clnesp.2020.04.010
    1. Barbui, C., Purgato, M., Abdulmalik, J., Acarturk, C., Eaton, J., Gastaldon, C., Gureje, O., Hanlon, C., Jordans, M., Lund, C., Nosè, M., Ostuzzi, G., Papola, D., Tedeschi, F., Tol, W., Turrini, G., Patel, V., & Thornicroft, G. (2020). Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: An umbrella review. The Lancet. Psychiatry, 7(2), 162-172. https://doi.org/10.1016/S2215-0366(19)30511-5
    1. Beba, M., Djafarian, K., & Shab-Bidar, S. (2019). Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 46, 81-86. https://doi.org/10.1016/j.ctim.2019.08.002

Publication types

LinkOut - more resources